ad4-mgag
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 30, 2013 (NCT01989533)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad4-mgag
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02771730 | Phase 1 | Mar 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), PaxVax, Inc. |
| NCT01989533 | Phase 1 | Oct 30, 2013 | National Institute of Allergy and Infectious Diseases (NIAID), PaxVax, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 1 | 1 | 2013 |
| PaxVax, Inc. | For profit | 2 | 1 | 1 | 2013 |
2 organizations
Page 1 / 1